Loading...
MacroGenics, Inc.
MGNX•NASDAQ
Healthcare
Biotechnology
$1.58
$0.02(1.28%)
MacroGenics, Inc. (MGNX) Financial Performance & Income Statement Overview
Review MacroGenics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
155.26%
↑ 155.26%
Operating Income Growth
34.28%
↑ 34.28%
Net Income Growth
-639.30%
↓ 639.30%
Operating Cash Flow Growth
12.57%
↑ 12.57%
Operating Margin
-65.25%
↓ 65.25%
Gross Margin
89.78%
↑ 89.78%
Net Profit Margin
-36.62%
↓ 36.62%
ROE
-59.84%
↓ 59.84%
ROIC
-58.80%
↓ 58.80%
MacroGenics, Inc. (MGNX) Income Statement & Financial Overview
Review MacroGenics, Inc.'s (MGNX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.73M | $110.71M | $10.80M | $9.10M |
| Cost of Revenue | $5.49M | $1.87M | $4.63M | $3.96M |
| Gross Profit | $12.24M | $108.84M | $6.16M | $5.15M |
| Gross Profit Ratio | $0.69 | $0.98 | $0.57 | $0.57 |
| R&D Expenses | $38.89M | $40.54M | $49.92M | $44.19M |
| SG&A Expenses | $27.81M | $14.10M | $14.42M | $14.71M |
| Operating Expenses | $65.08M | $54.65M | $64.34M | $58.90M |
| Total Costs & Expenses | $70.57M | $56.52M | $68.98M | $62.85M |
| Interest Income | $2.09M | $2.12M | $2.52M | $2.69M |
| Interest Expense | -$24000.00 | $0.00 | $6000.00 | $1.13M |
| Depreciation & Amortization | $2.05M | $1.83M | $1.81M | $1.84M |
| EBITDA | -$12.42M | $58.14M | -$53.85M | -$49.22M |
| EBITDA Ratio | -$0.70 | $0.53 | -$4.99 | -$5.41 |
| Operating Income | -$52.84M | $54.19M | -$58.18M | -$53.75M |
| Operating Income Ratio | -$2.98 | $0.49 | -$5.39 | -$5.90 |
| Other Income/Expenses (Net) | $38.36M | $2.12M | $2.52M | $1.56M |
| Income Before Tax | -$14.48M | $56.31M | -$55.66M | -$52.19M |
| Income Before Tax Ratio | -$0.82 | $0.51 | -$5.16 | -$5.73 |
| Income Tax Expense | $944000.00 | $0.00 | $0.00 | $1.80M |
| Net Income | -$15.42M | $56.31M | -$55.66M | -$52.19M |
| Net Income Ratio | -$0.87 | $0.51 | -$5.16 | -$5.73 |
| EPS | -$0.25 | $0.90 | -$0.89 | -$0.84 |
| Diluted EPS | -$0.25 | $0.90 | -$0.89 | -$0.84 |
| Weighted Avg Shares Outstanding | $62.62M | $62.74M | $62.66M | $62.29M |
| Weighted Avg Shares Outstanding (Diluted) | $62.62M | $62.87M | $62.66M | $62.29M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan